0000899243-15-006428.txt : 20151007
0000899243-15-006428.hdr.sgml : 20151007
20151007161715
ACCESSION NUMBER: 0000899243-15-006428
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151005
FILED AS OF DATE: 20151007
DATE AS OF CHANGE: 20151007
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ZOGENIX, INC.
CENTRAL INDEX KEY: 0001375151
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 205300780
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12400 HIGH BLUFF DRIVE
STREET 2: SUITE 650
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 259-1165
MAIL ADDRESS:
STREET 1: 12400 HIGH BLUFF DRIVE
STREET 2: SUITE 650
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: ZOGENIX INC
DATE OF NAME CHANGE: 20060911
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Galer Bradley S.
CENTRAL INDEX KEY: 0001594565
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34962
FILM NUMBER: 151149099
MAIL ADDRESS:
STREET 1: C/O ZOGENIX, INC.
STREET 2: 12400 HIGH BLUFF DR., SUITE 650
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-10-05
0
0001375151
ZOGENIX, INC.
ZGNX
0001594565
Galer Bradley S.
C/O ZOGENIX, INC.
12400 HIGH BLUFF DR., SUITE 650
SAN DIEGO
CA
92130
0
1
0
0
EVP/Chief Medical Officer
Stock Option (Right to Buy)
13.32
2015-10-05
4
A
0
30000
0.00
A
2025-10-04
Common Stock
30000
30000
D
The option was granted on October 5, 2015, which is the vesting commencement date. One-half of the shares subject to the option will vest in thirty-six equal monthly installments over the three-year period following the vesting commencement date, subject to the Reporting Person's continued employment with the Company on each vesting date. The remaining one-half of the shares subject to the option will vest based on the following performance milestone: the U.S. Food and Drug Administration's acceptance of the Company's New Drug Application for ZX008 on or before the three-year anniversary of the date of grant, subject to the Reporting Person's continued employment with the Company on such vesting date.
/s/ Thomas Doyle, Attorney-in-fact
2015-10-07